Redcare Pharmacy NVXSWX:RDC 48 5-Day RSI is 99.33 as of Jun. 27, 2026. GuruFocus rates XSWX:RDC with a GF Score™ of 48/100 and a GF Value™ of CHF143.20 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 697 Healthcare Providers & Services companies, Redcare Pharmacy NV ranks worse than 80.63% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The industry rank for Redcare Pharmacy NV's 5-Day RSI or its related term are showing as below:
XSWX:RDC's 5-Day RSI is ranked worse than 80.63% of 697
companies
in the Healthcare Providers & Services industry
Industry Median: 46.21
vs XSWX:RDC: 99.33
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
For the Pharmaceutical Retailers subindustry, Redcare Pharmacy NV's 5-Day RSI, along with its competitors' market caps and 5-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Redcare Pharmacy NV 5-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Redcare Pharmacy NV's 5-Day RSI distribution charts can be found below:
* The bar in red indicates where Redcare Pharmacy NV's 5-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Redcare Pharmacy NV (XSWX:RDC) has a 5-Day RSI of 99.33 as of Jun. 27, 2026. According to the industry distribution chart, Redcare Pharmacy NV ranks #562 out of 697 companies in the Healthcare Providers & Services industry, placing it in the top 80.6%.
Is Redcare Pharmacy NV's 5-Day RSI too high?
Redcare Pharmacy NV's current 5-Day RSI is 99.33. The Healthcare Providers & Services industry median 5-Day RSI is 46.21. Redcare Pharmacy NV's value of 99.33 is 115% above this industry median. Based on the distribution chart, Redcare Pharmacy NV ranks #562 out of 697 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Redcare Pharmacy NV has a GF Score™ of 48/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Redcare Pharmacy NV's 5-Day RSI compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Redcare Pharmacy NV ranks #562 out of 697 companies for 5-Day RSI. This places Redcare Pharmacy NV in the lower half of its industry. The industry median 5-Day RSI is 46.21. Redcare Pharmacy NV's value of 99.33 is 115% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Day RSI for a Healthcare Providers & Services company?
The median 5-Day RSI among Healthcare Providers & Services companies is 46.21, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a 5-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 5-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Redcare Pharmacy NV's current 5-Day RSI of 99.33 is 115% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Day RSI mean?
A high 5-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 5-Day RSI is 46.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Redcare Pharmacy NV's current 5-Day RSI is 99.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redcare Pharmacy NV stock overvalued right now?
Based on GuruFocus' analysis, Redcare Pharmacy NV (XSWX:RDC) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF143.20, compared to a current price of CHF60.95 — trading 57.4% below its estimated fair value. The current 5-Day RSI is 99.33 and 115% above the Healthcare Providers & Services industry median of 46.21. Redcare Pharmacy NV's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Day RSI calculated?
5-Day RSI is calculated from a company's financial statements. For Redcare Pharmacy NV (XSWX:RDC), the current 5-Day RSI is 99.33 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Redcare Pharmacy NV (XSWX:RDC) Overvalued in 2026?
Based on GuruFocus' analysis, Redcare Pharmacy NV stock appears to be undervalued.
The current stock price of CHF60.95 is trading 57.4% below its estimated GF Value™ of CHF143.20.
GuruFocus considers Redcare Pharmacy NV to be Significantly Undervalued.
Key valuation signals for XSWX:RDC:
5-Day RSI: 99.33
GF Value™: CHF143.20 vs. price of CHF60.95 (57.4% below fair value)
Industry Position: 115% above the Healthcare Providers & Services median (#562 of 697)
No single metric tells the full story. See the XSWX:RDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Redcare Pharmacy NV is an online pharmacy business for prescription and nonprescription (over-the-counter) pharmaceuticals, beauty and personal care products (BPC) and food supplements. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands. It operates in two segments, namely DACH segment that includes sales in Germany, Austria and Switzerland; and the International segment that includes sales across Belgium, the Netherlands, France and Italy. The DACH segment accounts for the majority of the revenue.
48GF Score
Get the complete analysis for XSWX:RDC
5-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:RDC has been successfully added to your 